Does tissue microarray analysis of hMSH2 expression predict outcome in men with prostate cancer?
hMSH2 is differentially expressed in malignant prostate tissue and hMSH2 immunohistochemical staining intensity correlates with Gleason score, overall and disease-free survival. Taken together our results suggest that hMSH2 expression may be a useful prognostic biomarker for outcome in men with clinically organ confined PC.
The presence of CRA may have protective effects against the development of AMD.